DD160279A5 - Verfahren zur herstellung eines die spezifitaet von mks-virus-antigenen aufweisenden polypeptits - Google Patents

Verfahren zur herstellung eines die spezifitaet von mks-virus-antigenen aufweisenden polypeptits Download PDF

Info

Publication number
DD160279A5
DD160279A5 DD81229946A DD22994681A DD160279A5 DD 160279 A5 DD160279 A5 DD 160279A5 DD 81229946 A DD81229946 A DD 81229946A DD 22994681 A DD22994681 A DD 22994681A DD 160279 A5 DD160279 A5 DD 160279A5
Authority
DD
German Democratic Republic
Prior art keywords
fmdv
dna
coli
dna sequences
sequences
Prior art date
Application number
DD81229946A
Other languages
German (de)
English (en)
Inventor
Peter H Hofschneider
Heinz Schaller
Hans A Kupper
Walter Keller
Vladimir Zaslavsky
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of DD160279A5 publication Critical patent/DD160279A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DD81229946A 1980-05-12 1981-05-11 Verfahren zur herstellung eines die spezifitaet von mks-virus-antigenen aufweisenden polypeptits DD160279A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8015635 1980-05-12
GB8026661 1980-08-15

Publications (1)

Publication Number Publication Date
DD160279A5 true DD160279A5 (de) 1983-05-25

Family

ID=26275483

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81229946A DD160279A5 (de) 1980-05-12 1981-05-11 Verfahren zur herstellung eines die spezifitaet von mks-virus-antigenen aufweisenden polypeptits

Country Status (15)

Country Link
EP (1) EP0040922A1 (cs)
AU (1) AU547096B2 (cs)
BR (1) BR8102922A (cs)
DD (1) DD160279A5 (cs)
DK (1) DK207681A (cs)
ES (2) ES8304204A1 (cs)
GR (1) GR74523B (cs)
IE (1) IE51178B1 (cs)
IL (1) IL62833A (cs)
IN (1) IN156358B (cs)
NO (1) NO811609L (cs)
PL (1) PL231111A1 (cs)
PT (1) PT73021B (cs)
YU (1) YU120581A (cs)
ZW (1) ZW11281A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860001557B1 (ko) * 1980-06-06 1986-10-04 비오겐 엔·브이 폴리펩티드의 제조방법
US4874702A (en) * 1980-09-08 1989-10-17 Biogen, Inc. Vectors and methods for making such vectors and for expressive cloned genes
NZ198388A (en) * 1980-09-18 1985-05-31 Wellcome Found Dna molecule comprising sequence substantially corresponding to at least part of foot and mouth disease virus rna;transformed host cell;antigen and vaccine
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
EP0068693A3 (en) * 1981-06-16 1983-07-20 Genentech, Inc. Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
US5230888A (en) * 1982-05-06 1993-07-27 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
EP0105481A1 (en) * 1982-09-30 1984-04-18 The Wellcome Foundation Limited Novel antigens and vaccines containing them
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
AU573574B2 (en) * 1983-03-08 1988-06-16 Chiron Mimotopes Pty Ltd Immunogenic deteminants of foot and mouth disease virus
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
BE901119A (fr) * 1984-11-23 1985-03-15 Wallone Region Procede de preparation de plasmides vecteurs capables de transformer un hote bacterien escherichia coli et d'y promouvoir et controler l'expression d'un adn heterologue.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US6479787B1 (en) 1999-10-05 2002-11-12 Rexam Ab Laser unit and method for engraving articles to be included in cans

Also Published As

Publication number Publication date
IL62833A0 (en) 1981-07-31
EP0040922A1 (en) 1981-12-02
IL62833A (en) 1984-12-31
ES8304204A1 (es) 1983-02-16
AU7045581A (en) 1981-12-10
IN156358B (cs) 1985-07-06
IE51178B1 (en) 1986-10-29
NO811609L (no) 1981-11-13
YU120581A (en) 1984-04-30
BR8102922A (pt) 1982-02-02
ZW11281A1 (en) 1982-04-21
PT73021B (en) 1983-10-19
ES511491A0 (es) 1983-06-16
PL231111A1 (en) 1983-07-18
GR74523B (cs) 1984-06-29
ES8307298A1 (es) 1983-06-16
ES502089A0 (es) 1982-12-16
AU547096B2 (en) 1985-10-03
IE811049L (en) 1981-11-12
PT73021A (en) 1981-06-01
DK207681A (da) 1981-11-13

Similar Documents

Publication Publication Date Title
DE69333036T2 (de) DNA-Fragmente, die für die Untereinheiten von dem Neisseria Meningitidis Rezeptor kodieren
DE60126249T2 (de) Heterologe expression von neisseria-proteinen
DE3049831C2 (de) Vektoren enthaltend eine f}r das Oberfl{chenantigen des Hepatites B-Virus kodierende Nucleotidsequenz, Verwendung dieser Vektoren zur Herstellung von Peptiden, Impfstoffe enhaltend dabei erhaltende Peptide als Antigen
DD160279A5 (de) Verfahren zur herstellung eines die spezifitaet von mks-virus-antigenen aufweisenden polypeptits
SU1414319A3 (ru) Способ получени лейкоцитарных интерферонов человека
DE3586853T2 (de) Immunologisch aktive Peptide, geeignet zur Einführung von Immunisierung gegen Malaria und deren Kodierung von Genen.
DE3588239T3 (de) Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
EP0418827B1 (de) Impfstoff gegen die Lyme-Krankheit
DD147855A5 (de) Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
DD160280A5 (de) Verfahren zur herstellung eines eine immunologische oder biologische aktivitaet von humanfibroblast-interferon aufweisenden polypeptids
DE69028479T2 (de) Genetische Manipulationen mit von RNA-Viren abgeleiteten Sequenzen enthaltendem rekombinantem DNA
DD203071A5 (de) Verfahren zur herstellung von rekombinant-dna-molekuele
DE68910590T2 (de) cDNAs, die für Mitglieder der Karzinoembryonalantigen-Familie kodieren.
DE3486110T2 (cs)
DE3687769T2 (de) Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
DD216044A5 (de) Verfahren zur herstellung eines rekombinierenden dna-klonierungsvektors
DE69132681T2 (de) Klonierung und Expression von Borrelia Lipoproteinen
DE3650319T2 (de) Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).
DE4005874A1 (de) Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
DE69101646T2 (de) Vakzine gegen Coccidiose.
DE68924916T2 (de) Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns.
DE3875043T2 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
DE3688924T2 (de) Synthetisches Schutzpeptid gegen Malaria und Kodierendes Gen.
DE3382718T2 (de) Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
JP3055687B2 (ja) Ｖｐ７をコードするヒトロタウイルス血清型４遺伝子９の分子クローニング、糖タンパク質特異的主要外部カプシド中和及びワクチンに使用するためのｖｐ７及びそのフラグメントの発現